Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 1997

View Archived Issues

Shaman patents new antifungal agents

New anticonvulsants from Howard University

Celltech reports new PDE IV inhibitors

Merck & Co. claims NMDA and AMPA antagonists for neurologic indications

Human IL-9 reported in patent literature

Sumitomo reports novel hCNTF variant

Suntory reports new agents for circulatory disorders

New 5-HT1A receptor ligands reported by Bayer

New cardiovascular agents from Sigma-Tau

Company Profile: CyberChemics

Company Profile: Calydon

n-Docosanol efficacy demonstrated in herpes labialis

Efficacy of Fujirebio antiulcer drug demonstrated

Hoechst launches antidiabetic drug in Germany

Function of breast cancer gene described

Viracept licensed to Roche

Hybridon granted patent coverage for orally administered hybrid compounds

First market introductions for Bondronat

Millennium and ChemGenics merge

New market for Mivacron

Synsorb product enters clinical trials

Allelix refocuses drug development program

Asta seeks rights to impotency Rx

GS-840 progresses through clinical trials

URSO to be evaluated as chemopreventive for colorectal cancer

Altus receives grant for nerve agent neutralization

Sequana and PE Applied Biosystems form Chinese joint venture

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...